[go: up one dir, main page]

Winchester et al., 2022 - Google Patents

Laboratory Diagnosis and Monitoring of Lysosomal Storage Diseases

Winchester et al., 2022

Document ID
3149756804895288442
Author
Winchester B
Beesley C
Burke D
Harvey K
Mills K
Heales S
Publication year
Publication venue
Lysosomal Storage Disorders: A Practical Guide

External Links

Snippet

The route to a definitive diagnosis is based upon the clinical presentation and genetic and bio chemical laboratory tests on blood and urine. The definitive diagnosis of lysosomal storage diseases (LSDs) is based upon demonstrating a genetic and functional defect in a …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
AU2019219727B2 (en) Method to predict response to pharmacological chaperone treatment of diseases
Gal et al. Toward a consensus in the laboratory diagnostics of Fabry disease-recommendations of a European expert group
Winchester et al. Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting
Wenger et al. Synthetic substrate ß‐glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease
Saito et al. Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST)
US20040166554A1 (en) Method for assaying the activity of lysosomal enzymes
Gheldof et al. Clinical implementation of gene panel testing for lysosomal storage diseases
Verma et al. Inherited metabolic disorders: prenatal diagnosis of lysosomal storage disorders
Meikle et al. Diagnosis of lysosomal storage disorders: current techniques and future directions
Winchester Lysosomal diseases: diagnostic update
Strovel et al. Measurement of lysosomal enzyme activities: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
Al-Sannaa et al. Lysosomal storage disorders (LSDs): the prevalence in the eastern Province of Saudi Arabia
Fuller Laboratory diagnosis of lysosomal diseases: newborn screening to treatment
JP2010139511A (en) Diagnosis of lysosomal storage disorders using saposin and other marker
Winchester et al. Biochemical and genetic diagnosis of Fabry disease
Li et al. Early prenatal diagnosis of lysosomal storage disorders by enzymatic and molecular analysis
Winchester Laboratory diagnosis of lysosomal storage diseases
Winchester et al. Laboratory Diagnosis and Monitoring of Lysosomal Storage Diseases
Poyatos‐Andújar et al. Prenatal mucopolysaccharidosis VII: a novel pathogenic variant identified in GUSB gene
Massaccesi et al. Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients
Sheth et al. Prenatal diagnosis of lysosomal storage disorders by enzymes study using chorionic villus and amniotic fluid
US7378231B1 (en) Diagnosis of lysosomal storage disorders using saposins and other markers
JP4703008B2 (en) Use of at least one saposin level for diagnosing or monitoring lysosomal storage disorders in a subject
US7361481B2 (en) Diagnosis of lysosomal storage disorders using saposins and other markers
Fuller et al. Functional assessment of the genetic findings indicating mucopolysaccharidosis type II in the prenatal setting